• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核苷酸多态性与卵巢癌风险的关联:系统评价和网络荟萃分析。

The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis.

机构信息

Department of Gastroenterology, The Second Xiangya Hospital, Central South University, Changsha, China.

Research Center of Digestive Disease, The Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

Cancer Med. 2023 Jan;12(1):541-556. doi: 10.1002/cam4.4891. Epub 2022 May 30.

DOI:10.1002/cam4.4891
PMID:35637613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9844622/
Abstract

BACKGROUND

The relationship between single nucleotide polymorphisms (SNPs) and ovarian cancer (OC) risk remains controversial. This systematic review and network meta-analysis was aimed to determine the association between SNPs and OC risk.

METHODS

Several databases (PubMed, EMBASE, China National Knowledge Infrastructure, Wanfang databases, China Science and Technology Journal Database, and China Biology Medicine disc) were searched to summarize the association between SNPs and OC published throughout April 2021. Direct meta-analysis was used to identify SNPs that could predict the incidence of OC. Ranking probability resulting from network meta-analysis and the Thakkinstian's algorithm was used to select the most appropriate gene model. The false positive report probability (FPRP) and Venice criteria were further tested for credible relationships. Subgroup analysis was also carried out to explore whether there are racial differences.

RESULTS

A total of 63 genes and 92 SNPs were included in our study after careful consideration. Fok1 rs2228570 is likely a dominant risk factor for the development of OC compared to other selected genes. The dominant gene model of Fok1 rs2228570 (pooled OR = 1.158, 95% CI: 1.068-1.256) was determined to be the most suitable model with a FPRP <0.2 and moderate credibility.

CONCLUSIONS

Fok1 rs2228570 is closely linked to OC risk, and the dominant gene model is likely the most appropriate model for estimating OC susceptibility.

摘要

背景

单核苷酸多态性(SNP)与卵巢癌(OC)风险之间的关系仍存在争议。本系统评价和网络荟萃分析旨在确定 SNP 与 OC 风险之间的关联。

方法

检索了多个数据库(PubMed、EMBASE、中国知网、万方数据库、中国科技期刊数据库和中国生物医学文献数据库),以总结截至 2021 年 4 月发表的 SNP 与 OC 相关的研究。直接荟萃分析用于确定可预测 OC 发生率的 SNP。网络荟萃分析和 Thakkinstian 算法的排序概率用于选择最合适的基因模型。进一步使用虚假阳性报告概率(FPRP)和威尼斯标准对可信关系进行测试。还进行了亚组分析,以探讨是否存在种族差异。

结果

经过仔细考虑,本研究共纳入 63 个基因和 92 个 SNP。与其他选定基因相比,Fok1 rs2228570 可能是 OC 发展的显性危险因素。Fok1 rs2228570 的显性基因模型(合并 OR=1.158,95%CI:1.068-1.256)被确定为最适合的模型,FPRP<0.2,可信度适中。

结论

Fok1 rs2228570 与 OC 风险密切相关,显性基因模型可能是估计 OC 易感性的最合适模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/46ba3dde8329/CAM4-12-541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/4712bbe5cd83/CAM4-12-541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/6294b0c36668/CAM4-12-541-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/424cc75859bd/CAM4-12-541-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/7b0e3b6cd29c/CAM4-12-541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/46ba3dde8329/CAM4-12-541-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/4712bbe5cd83/CAM4-12-541-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/6294b0c36668/CAM4-12-541-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/424cc75859bd/CAM4-12-541-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/7b0e3b6cd29c/CAM4-12-541-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2123/9844622/46ba3dde8329/CAM4-12-541-g002.jpg

相似文献

1
The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis.单核苷酸多态性与卵巢癌风险的关联:系统评价和网络荟萃分析。
Cancer Med. 2023 Jan;12(1):541-556. doi: 10.1002/cam4.4891. Epub 2022 May 30.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
6
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.维生素 D 受体的遗传多态性是否与乳腺癌/卵巢癌有关?系统评价和网络荟萃分析。
Gene. 2018 Nov 30;677:211-227. doi: 10.1016/j.gene.2018.07.070. Epub 2018 Jul 29.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Effect of novel IL-8 gene mutation on its protein structure and stability among ovarian cancer patients in Saudi Arabia.新型白细胞介素-8基因突变对沙特阿拉伯卵巢癌患者白细胞介素-8蛋白结构及稳定性的影响
Bioinformation. 2024 Nov 30;20(11):1671-1677. doi: 10.6026/9732063002001671. eCollection 2024.
2
Single nucleotide polymorphisms in ovarian cancer impacting lipid metabolism and prognosis: an integrated TCGA database analysis.影响脂质代谢和预后的卵巢癌单核苷酸多态性:一项整合的TCGA数据库分析
BMC Cancer. 2025 Mar 13;25(1):462. doi: 10.1186/s12885-025-13841-6.
3
The association of rs25487 of the  gene and rs13181 of the gene polymorphisms with the ovarian cancer risk.

本文引用的文献

1
Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis.XRCC3基因18067 C>T(Thr241Met)多态性与宫颈癌和卵巢癌风险的关联:一项系统评价和荟萃分析。
Interv Med Appl Sci. 2019 Oct 7;11(3):172-181. doi: 10.1556/1646.11.2019.21. eCollection 2020 Sep.
2
Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk.长非编码 RNA (lncRNA) GAS5 多态性 rs145204276 与癌症风险的关联。
J Int Med Res. 2021 Sep;49(9):3000605211039798. doi: 10.1177/03000605211039798.
3
Review of Mendelian Randomization Studies on Ovarian Cancer.
该基因的rs25487和该基因多态性的rs13181与卵巢癌风险的关联。
Biomol Biomed. 2025 Apr 3;25(5):1197-1204. doi: 10.17305/bb.2024.11314.
4
Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian Cancer.白细胞介素-16 基因的单核苷酸多态性 rs11556218、rs4778889、rs4072111 和 rs1131445 与卵巢癌的相关性。
Int J Mol Sci. 2024 Sep 24;25(19):10272. doi: 10.3390/ijms251910272.
5
Association of Four Interleukin-8 Polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes.四种白细胞介素-8多态性(-251 A>T、+781 C>T、+1633 C>T、+2767 A>T)与卵巢癌风险的关联:关注绝经状态和子宫内膜异位症相关亚型。
Biomedicines. 2024 Jan 30;12(2):321. doi: 10.3390/biomedicines12020321.
6
RAD51 and Infertility: A Review and Case-Control Study.RAD51与不孕不育:一项综述及病例对照研究
Biochem Genet. 2024 Apr;62(2):1216-1230. doi: 10.1007/s10528-023-10469-8. Epub 2023 Aug 10.
7
The relationship between single nucleotide polymorphisms and skin cancer susceptibility: A systematic review and network meta-analysis.单核苷酸多态性与皮肤癌易感性之间的关系:一项系统综述和网状Meta分析。
Front Oncol. 2023 Feb 15;13:1094309. doi: 10.3389/fonc.2023.1094309. eCollection 2023.
卵巢癌孟德尔随机化研究综述
Front Oncol. 2021 Aug 11;11:681396. doi: 10.3389/fonc.2021.681396. eCollection 2021.
4
Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study.维生素 D 水平和维生素 D 受体基因变异与非酒精性脂肪性肝病的风险相关:一项病例对照研究。
Front Endocrinol (Lausanne). 2021 Aug 6;12:648844. doi: 10.3389/fendo.2021.648844. eCollection 2021.
5
Future Screening Prospects for Ovarian Cancer.卵巢癌的未来筛查前景
Cancers (Basel). 2021 Jul 30;13(15):3840. doi: 10.3390/cancers13153840.
6
Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.个体和联合 GSTM1、GSTT1 和 GSTP1 多态性对肺癌风险的影响:系统荟萃分析的荟萃分析和再分析。
Medicine (Baltimore). 2021 Jul 2;100(26):e26104. doi: 10.1097/MD.0000000000026104.
7
Vitamin D Receptor (VDR) Gene Polymorphisms and Risk of Coronary Artery Disease (CAD): Systematic Review and Meta-analysis.维生素 D 受体(VDR)基因多态性与冠心病(CAD)风险:系统评价和荟萃分析。
Biochem Genet. 2021 Aug;59(4):813-836. doi: 10.1007/s10528-021-10038-x. Epub 2021 Feb 15.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization.采用孟德尔随机化方法对维生素 D 与癌症易感性之间的关联进行全面再评估。
Nat Commun. 2021 Jan 11;12(1):246. doi: 10.1038/s41467-020-20368-w.
10
The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies.5-还原酶在生理和代谢疾病中的作用:来自细胞、临床前和人体研究的证据。
J Steroid Biochem Mol Biol. 2021 Mar;207:105808. doi: 10.1016/j.jsbmb.2021.105808. Epub 2021 Jan 5.